Cargando…

Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model

BACKGROUND: The hypothalamus of the central nervous system is implicated in the development of diabetes due to its glucose-sensing function. Dysregulation of the hypothalamic glucose-sensing neurons leads to abnormal glucose metabolism. It has been described that fractalkine (FKN) is involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandur, Edina, Szabó, István, Hormay, Edina, Pap, Ramóna, Almási, Attila, Sipos, Katalin, Farkas, Viktória, Karádi, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549668/
https://www.ncbi.nlm.nih.gov/pubmed/36210435
http://dx.doi.org/10.1186/s13098-022-00919-5
_version_ 1784805722054197248
author Pandur, Edina
Szabó, István
Hormay, Edina
Pap, Ramóna
Almási, Attila
Sipos, Katalin
Farkas, Viktória
Karádi, Zoltán
author_facet Pandur, Edina
Szabó, István
Hormay, Edina
Pap, Ramóna
Almási, Attila
Sipos, Katalin
Farkas, Viktória
Karádi, Zoltán
author_sort Pandur, Edina
collection PubMed
description BACKGROUND: The hypothalamus of the central nervous system is implicated in the development of diabetes due to its glucose-sensing function. Dysregulation of the hypothalamic glucose-sensing neurons leads to abnormal glucose metabolism. It has been described that fractalkine (FKN) is involved in the development of hypothalamic inflammation, which may be one of the underlying causes of a diabetic condition. Moreover, iron may play a role in the pathogenesis of diabetes via the regulation of hepcidin, the iron regulatory hormone synthesis. MicroRNAs (miRNAs) are short non-coding molecules working as key regulators of gene expression, usually by inhibiting translation. Hypothalamic miRNAs are supposed to have a role in the control of energy balance by acting as regulators of hypothalamic glucose metabolism via influencing translation. METHODS: Using a miRNA array, we analysed the expression of diabetes, inflammation, and iron metabolism related miRNAs in the hypothalamus of a streptozotocin-induced rat type 1 diabetes model. Determination of the effect of miRNAs altered by STZ treatment on the target genes was carried out at protein level. RESULTS: We found 18 miRNAs with altered expression levels in the hypothalamus of the STZ-treated animals, which act as the regulators of mRNAs involved in glucose metabolism, pro-inflammatory cytokine synthesis, and iron homeostasis suggesting a link between these processes in diabetes. The alterations in the expression level of these miRNAs could modify hypothalamic glucose sensing, tolerance, uptake, and phosphorylation by affecting the stability of hexokinase-2, insulin receptor, leptin receptor, glucokinase, GLUT4, insulin-like growth factor receptor 1, and phosphoenolpyruvate carboxykinase mRNA molecules. Additional miRNAs were found to be altered resulting in the elevation of FKN protein. The miRNA, mRNA, and protein analyses of the diabetic hypothalamus revealed that the iron import, export, and iron storage were all influenced by miRNAs suggesting the disturbance of hypothalamic iron homeostasis. CONCLUSION: It can be supposed that glucose metabolism, inflammation, and iron homeostasis of the hypothalamus are linked via the altered expression of common miRNAs as well as the increased expression of FKN, which contribute to the imbalance of energy homeostasis, the synthesis of pro-inflammatory cytokines, and the iron accumulation of the hypothalamus. The results raise the possibility that FKN could be a potential target of new therapies targeting both inflammation and iron disturbances in diabetic conditions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00919-5.
format Online
Article
Text
id pubmed-9549668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95496682022-10-11 Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model Pandur, Edina Szabó, István Hormay, Edina Pap, Ramóna Almási, Attila Sipos, Katalin Farkas, Viktória Karádi, Zoltán Diabetol Metab Syndr Research BACKGROUND: The hypothalamus of the central nervous system is implicated in the development of diabetes due to its glucose-sensing function. Dysregulation of the hypothalamic glucose-sensing neurons leads to abnormal glucose metabolism. It has been described that fractalkine (FKN) is involved in the development of hypothalamic inflammation, which may be one of the underlying causes of a diabetic condition. Moreover, iron may play a role in the pathogenesis of diabetes via the regulation of hepcidin, the iron regulatory hormone synthesis. MicroRNAs (miRNAs) are short non-coding molecules working as key regulators of gene expression, usually by inhibiting translation. Hypothalamic miRNAs are supposed to have a role in the control of energy balance by acting as regulators of hypothalamic glucose metabolism via influencing translation. METHODS: Using a miRNA array, we analysed the expression of diabetes, inflammation, and iron metabolism related miRNAs in the hypothalamus of a streptozotocin-induced rat type 1 diabetes model. Determination of the effect of miRNAs altered by STZ treatment on the target genes was carried out at protein level. RESULTS: We found 18 miRNAs with altered expression levels in the hypothalamus of the STZ-treated animals, which act as the regulators of mRNAs involved in glucose metabolism, pro-inflammatory cytokine synthesis, and iron homeostasis suggesting a link between these processes in diabetes. The alterations in the expression level of these miRNAs could modify hypothalamic glucose sensing, tolerance, uptake, and phosphorylation by affecting the stability of hexokinase-2, insulin receptor, leptin receptor, glucokinase, GLUT4, insulin-like growth factor receptor 1, and phosphoenolpyruvate carboxykinase mRNA molecules. Additional miRNAs were found to be altered resulting in the elevation of FKN protein. The miRNA, mRNA, and protein analyses of the diabetic hypothalamus revealed that the iron import, export, and iron storage were all influenced by miRNAs suggesting the disturbance of hypothalamic iron homeostasis. CONCLUSION: It can be supposed that glucose metabolism, inflammation, and iron homeostasis of the hypothalamus are linked via the altered expression of common miRNAs as well as the increased expression of FKN, which contribute to the imbalance of energy homeostasis, the synthesis of pro-inflammatory cytokines, and the iron accumulation of the hypothalamus. The results raise the possibility that FKN could be a potential target of new therapies targeting both inflammation and iron disturbances in diabetic conditions. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-022-00919-5. BioMed Central 2022-10-10 /pmc/articles/PMC9549668/ /pubmed/36210435 http://dx.doi.org/10.1186/s13098-022-00919-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pandur, Edina
Szabó, István
Hormay, Edina
Pap, Ramóna
Almási, Attila
Sipos, Katalin
Farkas, Viktória
Karádi, Zoltán
Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title_full Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title_fullStr Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title_full_unstemmed Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title_short Alterations of the expression levels of glucose, inflammation, and iron metabolism related miRNAs and their target genes in the hypothalamus of STZ-induced rat diabetes model
title_sort alterations of the expression levels of glucose, inflammation, and iron metabolism related mirnas and their target genes in the hypothalamus of stz-induced rat diabetes model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549668/
https://www.ncbi.nlm.nih.gov/pubmed/36210435
http://dx.doi.org/10.1186/s13098-022-00919-5
work_keys_str_mv AT panduredina alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT szaboistvan alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT hormayedina alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT papramona alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT almasiattila alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT siposkatalin alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT farkasviktoria alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel
AT karadizoltan alterationsoftheexpressionlevelsofglucoseinflammationandironmetabolismrelatedmirnasandtheirtargetgenesinthehypothalamusofstzinducedratdiabetesmodel